Cargando…

Breakthrough SARS-CoV-2 Infections in Prison after Vaccination

Detalles Bibliográficos
Autores principales:	Brinkley-Rubinstein, Lauren, Peterson, Meghan, Martin, Rosemarie, Chan, Philip, Berk, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279089/ https://www.ncbi.nlm.nih.gov/pubmed/34233109 http://dx.doi.org/10.1056/NEJMc2108479

Ejemplares similares

Initial SARS-CoV-2 Vaccination Uptake in a Correctional Setting: Cross-sectional Study
por: Berk, Justin, et al.
Publicado: (2021)

Authors’ Response to Peer Reviews of “SARS-CoV-2 Vaccination Uptake in a Correctional Setting: Cross-sectional Study”
por: Berk, Justin, et al.
Publicado: (2021)

MAb for symptomatic COVID-19 in correctional facilities: an important opportunity
por: Berk, Justin, et al.
Publicado: (2021)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison
por: Chin, Elizabeth T., et al.
Publicado: (2021)

Suicides in state prisons in the United States: Highlighting gaps in data
por: LeMasters, Katherine, et al.
Publicado: (2023)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

COVID-19 community spread and consequences for prison case rates
por: LeMasters, Katherine, et al.
Publicado: (2022)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Why we vaccinate incarcerated people first
por: Berk, Justin, et al.
Publicado: (2021)

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
por: Chen, Shiqi, et al.
Publicado: (2023)

Emerging vaccine-breakthrough SARS-CoV-2 variants
por: Wang, Rui, et al.
Publicado: (2021)

SARS-CoV-2 incidence and vaccine escape
por: Thompson, Robin N, et al.
Publicado: (2021)

Effect of Vaccination on Transmission of SARS-CoV-2
por: Shah, Anoop S.V., et al.
Publicado: (2021)

Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Post SARS-CoV-2 vaccination effluvium
por: Luu, Ngoc-Nhi C., et al.
Publicado: (2023)

SARS-CoV-2 vaccines and donor recruitment for FMT
por: Ianiro, Gianluca, et al.
Publicado: (2021)

A strategy for SARS-CoV-2 vaccination in Yemen
por: Nasser, Abdullah, et al.
Publicado: (2021)

Ophthalmologic compromise following SARS-CoV-2 vaccinations
por: Finsterer, Josef
Publicado: (2022)

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Prison Population Reductions and COVID-19: A Latent Profile Analysis Synthesizing Recent Evidence From the Texas State Prison System
por: Vest, Noel, et al.
Publicado: (2020)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story
por: Cirillo, Nicola, et al.
Publicado: (2021)

SARS-CoV-2 vaccination related hyperthyroidism of Graves’ disease
por: Shih, Shyang-Rong, et al.
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Ko, Humphrey H T
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Knol, Mirjam J, et al.
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Franco-Paredes, Carlos
Publicado: (2022)

Tolerability and impact of SARS-CoV-2 vaccination in elite athletes
por: Hull, James H, et al.
Publicado: (2022)

Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination
por: Sprute, Rosanne, et al.
Publicado: (2022)

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
por: Harris, Ross J., et al.
Publicado: (2021)

SARS-CoV-2 vaccination triggered Guillain-Barre syndrome
por: Scorza, Fulvio A, et al.
Publicado: (2022)

Development of Schamberg's disease after SARS‐CoV‐2 vaccination
por: Morimoto, Hiroki, et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022)

Attitudes of vaccination service providers to the SARS-CoV-2 intranasal spray vaccine during the SARS-CoV-2 pandemic in China: A cross-sectional study
por: Cao, Yanlin, et al.
Publicado: (2023)

SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability
por: Foster, Charles S.P., et al.
Publicado: (2022)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Lodge, Archie
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gern1ok5hffk2skhenpq7qcksn